Neurodegenerative Disorder

News

August 23, 2023

1 min read

Save

Astrocyte Pharmaceuticals gets $6M to advance novel brain injury therapeutic

A Boston-area clinical stage drug discovery and development company announced $6 million in pre-Series B bridge financing to advance a novel cerebroprotectant therapeutic intended to treat a broad range of acute brain injuries.